Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Dormant
Current status date:
2022-07-19
Original market date: See footnote 1
2001-01-31
Product name:
ATRIDOX
DIN:
02242473
Product Monograph/Veterinary Labelling:
Date:
2021-06-28
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
DEN-MAT HOLDINGS, LLC
1017 W. Central Ave.
Lompoc
California
United States
93436-2701
Class:
Human
Dosage form(s):
Gel (Controlled-Release)
Route(s) of administration:
Subgingival
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
52:04.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
A01AB22 DOXYCYCLINE
Active ingredient group (AIG) number:See footnote5
0105569007
Active ingredient(s) See footnote8 | Strength |
---|---|
DOXYCYCLINE (DOXYCYCLINE HYCLATE) | 8.8 % / W/W |